SP
Therapeutic Areas
Recordati Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rare Disease Portfolio | Cushing's Disease, Acromegaly, Acute Hepatic Porphyrias | Marketed |
| Specialty & Primary Care Portfolio | Cardiovascular, Urology, Mental Health | Marketed |
Leadership Team at Recordati
RK
Robert Koremans
Chief Executive Officer
MM
Mike McClellan
Chief Financial Officer
AM
Alberto Martinez
Executive VP Specialty & Primary Care Business Unit
BB
Bibianne Bon
Group Chief Legal Officer
AA
Alessandra Abate
Group Chief People and Culture Officer
GF
Gabriele Finzi
Executive VP Corporate Development, Licensing & Innovation
MZ
Milan Zdravkovic
Executive VP Research & Development and Chief Medical Officer
AG
Alessandro Gilio
Executive VP Group Industrial Operations